As shown in Fig. S5e–h, DFO treatment significantly suppressed tumor growth and the cellular iron level compared to those in the control group, while overexpression of LncRIM partially restored tumor growth rate and the cellular iron level, as indicated by Ki67 and YAP levels and enhanced DAB iron-staining assay. This evidence concerns the gene YAP1 and neoplasm.